Medicrea Reports 1Q19 Revenue of €7.7MM, +10.6% vs. 1Q18

Medicrea posted 1Q19 revenue of €7.7MM (USD $9.5MM), +10.6% vs. 1Q18. U.S. sales, which represent just over half of the company’s revenue, grew 15% quarter over quarter. The number of UNiD patient-specific surgeries in the U.S. grew 68% in that same time frame.

In 2018, Medicrea discontinued two “non-strategic” products (mainly biologics)...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0